WPI 2344 Pill - brown oval
Pill with imprint WPI 2344 is Brown, Oval and has been identified as Lacosamide 150 mg. It is supplied by Actavis Pharma, Inc.
Lacosamide is used in the treatment of Seizures; Epilepsy and belongs to the drug class miscellaneous anticonvulsants. Risk cannot be ruled out during pregnancy. Lacosamide 150 mg is classified as a Schedule 5 controlled substance under the Controlled Substance Act (CSA).
Images for WPI 2344
Lacosamide
- Imprint
- WPI 2344
- Strength
- 150 mg
- Color
- Brown
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Miscellaneous anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 5 - Some potential for abuse
- Labeler / Supplier
- Actavis Pharma, Inc.
- National Drug Code (NDC)
- 00591-2344
More about lacosamide
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (174)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous anticonvulsants
- Breastfeeding
- En español
Patient resources
- Lacosamide oral/injection drug information
- Lacosamide (Intravenous) (Advanced Reading)
- Lacosamide (Oral) (Advanced Reading)
- Lacosamide Injection
- Lacosamide Oral Solution
- Lacosamide Tablets
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
